Loading viewer...
earnings
Format: PDF earnings
Telix Pharmaceuticals' H1 2023 results presentation covering the company's investigational radiopharmaceutical products and pipeline, including Illuccix® (Ga-68 gozetotide injection). The presentation outlines Telix's activities, financial results, and development progress as of August 2023.
annual_report
14 Pages
earnings
70 Pages
Bank of Georgia Group
Live Oak Bancshares Q4 2016 Earnings Presentation
earningsearnings
13 Pages
Live Oak Bancshares
Hang Lung Properties 2023 Interim Results Presentation
earningsearnings
82 Pages
Hang Lung Properties Limited
SBI Card Q2 FY22 Investor Presentation October 2021
earningsearnings
28 Pages
SBI Card and Payment Services Limited